IN2013MU02799A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02799A
IN2013MU02799A IN2799MU2013A IN2013MU02799A IN 2013MU02799 A IN2013MU02799 A IN 2013MU02799A IN 2799MU2013 A IN2799MU2013 A IN 2799MU2013A IN 2013MU02799 A IN2013MU02799 A IN 2013MU02799A
Authority
IN
India
Prior art keywords
synthesize
liquid crystalline
cholesterol unit
ferrocene
present
Prior art date
Application number
Other languages
English (en)
Inventor
M V Ramana Dr M
Dinesh Nivrutti Navale
Santosh Waghu Zote
Original Assignee
M V Ramana Dr M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M V Ramana Dr M filed Critical M V Ramana Dr M
Priority to IN2799MU2013 priority Critical patent/IN2013MU02799A/en
Publication of IN2013MU02799A publication Critical patent/IN2013MU02799A/en

Links

Landscapes

  • Steroid Compounds (AREA)
IN2799MU2013 2013-08-28 2013-08-28 IN2013MU02799A (he)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2799MU2013 IN2013MU02799A (he) 2013-08-28 2013-08-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2799MU2013 IN2013MU02799A (he) 2013-08-28 2013-08-28

Publications (1)

Publication Number Publication Date
IN2013MU02799A true IN2013MU02799A (he) 2015-07-03

Family

ID=54396091

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2799MU2013 IN2013MU02799A (he) 2013-08-28 2013-08-28

Country Status (1)

Country Link
IN (1) IN2013MU02799A (he)

Similar Documents

Publication Publication Date Title
UY34825A (es) Síntesis de compuestos heterocíclicos
BR112016029333A2 (pt) síntese de compostos de carbamoilpiridona policíclico
MY179781A (en) Biaryl inhibitors of bruton's tyrosine kinase
GEP20237496B (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
NZ702752A (en) Methods for synthesizing amatoxin building block and amatoxins
MY174025A (en) Azole silane compound, surface treatment solution, surface treatment method, and use thereof
MX364825B (es) Composiciones y metodos para obtener (r)-reticulina y precursores de las misma.
PH12016500225A1 (en) Novel quinoline-substituted compound
MX2015015417A (es) Inhibidores de acetil-coa carboxilasa (acc) y usos de los mismos.
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
IN2015DN03998A (he)
EA201101675A1 (ru) Спироэпоксиды как промежуточные продукты синтеза
EA201590250A1 (ru) Производные карбамат/мочевины
MX2015016332A (es) Inhibidores de alk biciclicos fusionados.
EA201692270A1 (ru) Производные нафтиридиндиона
MX2016008418A (es) Metodos y reactivos para el radiomarcaje.
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
MX2016001641A (es) Ciclobutilcarboxamidas como nematicidas.
NZ702239A (en) Heteroaryl compounds and methods of use thereof
MX2016016202A (es) Inhibidores de molecula pequeña de antigeno-1 asociado a funcion de linfocitos (lfa-1).
MX2015014470A (es) Analogos de combretastatina.
IN2013MU02799A (he)
ECSP13012735A (es) Nuevo procedimiento de síntesis de la agomelatina
IN2013MU02801A (he)
IN2013DE03665A (he)